Apalutamide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Apalutamide
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Apalutamide

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Apalutamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 13 USDMF, 4 EU WC, 2 KDMF, 9 NDC API, 26 Listed Suppliers, $ API Reference Price

36 API Suppliers
13 USDMF
4 EU WC
2 KDMF
9 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

97 Drugs in Development

97 Drugs in Development

INTERMEDIATES

27 Intermediate Suppliers

27 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 3 FDA Orange Book, 2 Europe, 2 Canada, 2 Australia, 1 South Africa, 2 Listed Dossiers

12 FDF Dossiers
3 FDA Orange Book
2 Europe
2 Canada
2 Australia
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 3 Gangwal Healthcare, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 5 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 4 Kerry, 2 Keval Exports, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
4 DKSH
3 Gangwal Healthcare
3 Actylis
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
9 BASF
5 Corel Pharma Chem
3 DFE Pharma
1 Esteem Industries
1 Finar
7 Gangwal Chemicals
2 Ideal Cures
1 Ingredion Pharma Solutions
4 Kerry
2 Keval Exports
7 Microlex e.U
2 Nitika Pharmaceutical Specialities
2 Nomisma Healthcare
1 Novo Excipients
1 Pharmatrans-Sanaq
2 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 19 Coating Systems & Additives, 14 Disintegrants & Superdisintegrants, 13 Thickeners and Stabilizers, 12 Controlled & Modified Release, 12 Lubricants & Glidants, 9 Direct Compression, 9 Topical, 8 Granulation, 7 Co-Processed Excipients, 4 Film Formers & Plasticizers, 4 Solubilizers, 3 Chewable & Orodispersible Aids, 3 Taste Masking, 3 Coloring Agents, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Parenteral

21 Fillers, Diluents & Binders
19 Coating Systems & Additives
14 Disintegrants & Superdisintegrants
13 Thickeners and Stabilizers
12 Controlled & Modified Release
12 Lubricants & Glidants
9 Direct Compression
9 Topical
8 Granulation
7 Co-Processed Excipients
4 Film Formers & Plasticizers
4 Solubilizers
3 Chewable & Orodispersible Aids
3 Taste Masking
3 Coloring Agents
3 Emulsifying Agents
2 API Stability Enhancers
2 Rheology Modifiers
1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 57 News #PharmaBuzz

1 Data Compilation #PharmaFlow
57 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

5 APIs, 5 FDF Dossiers

5 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

34 US Patents, 6 Health Canada Patents

34 US Patents
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 8,224 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Belmore Neidrauer LLP

filter Patent Reset all filters

6 All

01 22875767

02 22885415

03 23008345

filter Product Reset all filters

6 All

01 6APALUTAMIDE

filter Dosage Reset all filters

6 All

01 6TABLET

filter Exp Date Reset all filters

6 All

01 42033-06-04

02 22033-09-23

Product Main Page

01

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-04

Date Granted : 2018-08-14

Apalutamide

Brand Name : ERLEADA

Patent Number : 2875767

Filing Date : 2013-06-04

Strength per Unit : 60mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-06-04

Date Granted : 2018-08-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-04

Date Granted : 2019-10-22

Apalutamide

Brand Name : ERLEADA

Patent Number : 3008345

Filing Date : 2013-06-04

Strength per Unit : 60mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-06-04

Date Granted : 2019-10-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-23

Date Granted : 2021-06-29

Apalutamide

Brand Name : ERLEADA

Patent Number : 2885415

Filing Date : 2013-09-23

Strength per Unit : 60mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-09-23

Date Granted : 2021-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-04

Date Granted : 2018-08-14

Apalutamide

Brand Name : ERLEADA

Patent Number : 2875767

Filing Date : 2013-06-04

Strength per Unit : 240mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-06-04

Date Granted : 2018-08-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-09-23

Date Granted : 2021-06-29

Apalutamide

Brand Name : ERLEADA

Patent Number : 2885415

Filing Date : 2013-09-23

Strength per Unit : 240mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-09-23

Date Granted : 2021-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Belmore Neidrauer LLP

Apalutamide

Peptide Process CMC

Not Confirmed

Belmore Neidrauer LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-04

Date Granted : 2019-10-22

Apalutamide

Brand Name : ERLEADA

Patent Number : 3008345

Filing Date : 2013-06-04

Strength per Unit : 240mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-06-04

Date Granted : 2019-10-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!